ReShape Lifesciences (NASDAQ:RSLS) Shares Cross Above 200-Day Moving Average – Time to Sell?

Shares of ReShape Lifesciences Inc. (NASDAQ:RSLS) passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $0.54 and traded as high as $5.60. ReShape Lifesciences shares last traded at $5.05, with a volume of 54,097 shares.

Analyst Upgrades and Downgrades

Separately, Maxim Group reaffirmed a “hold” rating on shares of ReShape Lifesciences in a research report on Wednesday, July 17th.

ReShape Lifesciences Trading Down 1.4 %

The company’s 50 day moving average price is $1.29 and its 200 day moving average price is $0.57.

ReShape Lifesciences (NASDAQ:RSLS) last issued its quarterly earnings data on Wednesday, August 14th. The medical device company reported ($0.06) EPS for the quarter. ReShape Lifesciences had a negative return on equity of 208.37% and a negative net margin of 112.11%. The firm had revenue of $1.97 million for the quarter.

About ReShape Lifesciences

ReShape Lifesciences Inc provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; Lap-Band 2.0 System, an adjustable postoperatively to increase or decrease the pressure to the band in order to optimize an individual's comfort and therapy effectiveness; and ReShape Calibration Tubes, that fits the lesser curvature of the stomach to reach the pylorus.